N-Acetyl (3,4-Dihydroxybutyl) Cysteine Test · Urine

1,3-butadiene is a colorless gas you cannot see or smell, released by tobacco smoke, vehicle exhaust, gas stoves, and industrial plants that make rubber and plastics. Once you breathe it in, your body breaks it down and excretes the leftover pieces in urine. DHBMA (N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine) is one of those leftover pieces, and measuring it tells you how much 1,3-butadiene your body has actually had to deal with recently.

This is not a disease test. It is an exposure test. Higher numbers mean more pollutant moving through your body, and a series of large population studies has now linked higher urinary DHBMA to higher rates of heart attack, kidney disease, hypertension, hearing loss, and accelerated muscle and joint aging. If you live in a city, work in certain industries, or live with a smoker, this is the kind of background risk that never shows up on a standard lipid or metabolic panel.

What This Test Actually Measures

When 1,3-butadiene enters your body, it gets converted into reactive forms that can damage DNA and proteins. To neutralize them, your body links them to a small protective molecule (a sulfur-containing amino acid called cysteine), wraps the package up, and dumps it through the kidneys. DHBMA is one specific version of that finished package. The amount in your urine reflects roughly how much 1,3-butadiene you were exposed to over the prior day or two.

Because it is excreted in urine, results are usually reported relative to creatinine (a kidney marker used to correct for how dilute or concentrated your urine sample happens to be). This matters: hydration alone can shift the raw concentration, but the creatinine-corrected value is what tracks with actual exposure.

Heart Attack and Cardiovascular Risk

Of all the urinary pollutant markers analyzed in a cross-sectional study of 5,211 US adults, DHBMA carried the heaviest weight in predicting myocardial infarction (heart attack). Within a mixture-modeling analysis of 19 different volatile organic compound metabolites, DHBMA scored the highest contribution at 0.27, meaning it was the single most influential exposure marker driving the link between this pollutant class and heart attack risk.

A separate study in 4,430 US nonsmokers from the same NHANES dataset found that people in the highest quartile of urinary DHBMA had higher systolic blood pressure and a higher prevalence of stage 2 hypertension than those with the lowest exposure. The takeaway is consistent: even at exposure levels common in the general population, more 1,3-butadiene moving through your body is tracking with more pressure on your cardiovascular system.

In a study of 853 adolescents and young adults, higher urinary DHBMA correlated with higher LDL cholesterol, thicker carotid artery walls (carotid intima-media thickness, an early measure of artery aging), more circulating endothelial microparticles (fragments released by stressed blood vessel cells), and higher 8-OHdG (a urinary marker of DNA damage from oxidative stress). This is the cleanest available signal that 1,3-butadiene exposure is tied to early vascular changes long before symptoms appear.

Kidney Disease

In a machine-learning analysis of NHANES data, higher urinary DHBMA was associated with about 95% higher odds of chronic kidney disease (odds ratio approximately 1.95). The kidneys are responsible for clearing this metabolite, and they appear to take damage from the parent pollutant in the process. If your kidneys are filtering large amounts of reactive butadiene byproducts day after day, that filtration burden may contribute to the loss of function picked up on standard kidney panels.

Sarcopenia and Joint Aging

In a study of 2,429 US adults, urinary DHBMA was identified as an independent risk factor for sarcopenia (age-related muscle loss), with roughly 4.5 times higher odds in people with high exposure. The proposed mechanism involves chronic low-grade inflammation and stress on muscle protein synthesis pathways. A separate machine-learning analysis of 3,683 adults flagged DHBMA as a significant non-linear risk factor for osteoarthritis as well.

Hearing Loss

Higher urinary DHBMA has been independently associated with worse overall hearing thresholds and worse high-frequency hearing in a Korean adult population. The inner ear is unusually sensitive to oxidative stress, and 1,3-butadiene appears to act as a slow-acting ototoxin (a substance that damages hearing). The authors specifically called for reducing 1,3-butadiene exposure in everyday life as a hearing preservation strategy.

Inflammation and Other Associations

In a study of 7,007 adults, DHBMA was among the urinary pollutant metabolites positively associated with two systemic inflammation indices (SII and SIRI, which combine routine blood cell counts into a single inflammation score). Smokers were identified as the most vulnerable subgroup. Higher DHBMA has also been observed in adults with atopic dermatitis, though that association weakened after statistical correction.

How to Read Your Result

DHBMA is currently a research-grade exposure biomarker. There are no consensus clinical cutpoints from major guideline bodies, no universally accepted optimal target, and no validated thresholds for action. What the literature consistently shows is a dose-response pattern: higher quartiles or higher creatinine-corrected concentrations are associated with worse outcomes than lower ones, in a roughly graded way.

These ranges are illustrative orientation drawn from population studies in NHANES and similar cohorts measured by mass spectrometry. They are not clinical targets. Your lab will likely report different numbers depending on its assay and reference population.

Compare your result within the same lab over time for the most meaningful trend. A single number tells you less than a series.

Tracking Your Trend

Urinary DHBMA reflects exposure over the previous one to two days, which means a single sample is essentially a snapshot of last week's air. It will move with where you live, where you work, whether you were near a smoker, whether you were stuck in traffic, and even what kind of stove you cooked on. One reading cannot tell you what your typical exposure looks like.

Get a baseline. If the result is in the upper range, identify likely exposure sources (smoking, secondhand smoke, occupational settings, gas appliances, traffic) and retest 8 to 12 weeks after making changes. Once stable, an annual recheck is reasonable for ongoing monitoring, especially if you live in an urban environment or have other cardiovascular risk factors. Series matter more than singles, because the goal is to see whether your trajectory is improving.

What to Do With an Elevated Result

An elevated DHBMA result is not a diagnosis. It is a signal that your body is processing more of a known industrial pollutant than is ideal. The first step is identifying the source: tobacco smoke (your own or others') is the single largest contributor for most people, followed by occupational exposure, traffic-heavy environments, and indoor combustion sources like gas stoves without ventilation.

Worth pairing the result with: a urinalysis and creatinine-based kidney function panel (eGFR, cystatin C) given the kidney associations, a lipid panel and hs-CRP (high-sensitivity C-reactive protein, a measure of inflammation) given the cardiovascular and inflammatory associations, and a blood pressure check at home. If multiple of these are off alongside a high DHBMA, the pattern is more meaningful than any single value, and a clinician familiar with environmental medicine or preventive cardiology can help map a follow-up.

Why This Matters Even If Your Standard Labs Look Fine

Standard panels measure what your body has already become. Cholesterol levels reflect years of metabolism. Kidney filtration declines years after the exposures that caused it. DHBMA captures something different: what your body is actively dealing with right now. That makes it a forward-looking signal, useful for catching environmental contributors to disease while you can still change them.